(Q21032652)

27 July 2022

8

Alister G Craig

Alister G

Craig

1 reference

27 July 2022

Marita Troye-Blomberg

6

object named as

Marita Troye-Blomberg

Marita

Troye-Blomberg

1 reference

27 July 2022

Mark J Geels

1

Mark J

Geels

1 reference

27 July 2022

Nathalie Imbault

3

Nathalie

Imbault

1 reference

27 July 2022

Harry van Schooten

4

Harry

van Schooten

1 reference

27 July 2022

Terry McWade

5

Terry

McWade

1 reference

27 July 2022

Roland Dobbelaer

7

Roland

Dobbelaer

1 reference

27 July 2022

Odile Leroy

9

Odile

Leroy

1 reference

Expert Review of Vaccines

27 July 2022

language of work or name

English

0 references

publication date

December 2011

0 references

published in

0 references

volume

10

0 references

issue

12

0 references

page(s)

1697-1708

0 references

cites work

Rescuing the bottom billion through control of neglected tropical diseases

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.158

Estimates of the burden of malaria morbidity in Africa in children under the age of 5 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.158

Protective efficacy of malaria case management and intermittent preventive treatment for preventing malaria mortality in children: a systematic review for the Lives Saved Tool

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.158

Effect of a fall in malaria transmission on morbidity and mortality in Kilifi, Kenya

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.158

A research agenda for malaria eradication: vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.158

Duration of protection with RTS,S/AS02A malaria vaccine in prevention of Plasmodium falciparum disease in Mozambican children: single-blind extended follow-up of a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.158

From the circumsporozoite protein to the RTS, S/AS candidate vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.158

The RTS,S vaccine candidate for malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.158

The mysteries of immunity to malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.158

Advances and challenges in malaria vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.158

Acquired immunity to malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.158

European Malaria Vaccine Initiative: portfolio and perspectives for the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.158

Safety and immunogenicity of a recombinant Plasmodium falciparum AMA1 malaria vaccine adjuvanted with Alhydrogel, Montanide ISA 720 or AS02.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.158

Allelic diversity and naturally acquired allele-specific antibody responses to Plasmodium falciparum apical membrane antigen 1 in Kenya

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.158

Lack of allele-specific efficacy of a bivalent AMA1 malaria vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.158

A Plasmodium falciparum GLURP-MSP3 chimeric protein; expression in Lactococcus lactis, immunogenicity and induction of biologically active antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.158

Safety and immunogenicity of GMZ2 - a MSP3-GLURP fusion protein malaria vaccine candidate

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.158

Safety and immunogenicity of the malaria vaccine candidate GMZ2 in malaria-exposed, adult individuals from Lambaréné, Gabon

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.158

A human Phase I/IIa malaria challenge trial of a polyprotein malaria vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.158

Protection against malaria by MSP3 candidate vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.158

Safety and immunogenicity of the malaria vaccine candidate MSP3 long synthetic peptide in 12-24 months-old Burkinabe children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.158

Apical membrane antigen 1: a malaria vaccine candidate in review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.158

Malaria vaccines - how and when to proceed?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.158

Rapid identification of malaria vaccine candidates based on alpha-helical coiled coil protein motif

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.158

Malaria vaccine candidate: design of a multivalent subunit α-helical coiled coil poly-epitope

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.158

Immunogenicity of a recombinant malaria vaccine based on receptor binding domain of Plasmodium falciparum EBA-175.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.158

Association between naturally acquired antibodies to erythrocyte-binding antigens of Plasmodium falciparum and protection from malaria and high-density parasitemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.158

Prime-boost vectored malaria vaccines: progress and prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.158

Single-dose immunogenicity and protective efficacy of simian adenoviral vectors against Plasmodium berghei

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.158

Immunological mechanisms underlying protection mediated by RTS,S: a review of the available data

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.158

A DNA prime-modified vaccinia virus ankara boost vaccine encoding thrombospondin-related adhesion protein but not circumsporozoite protein partially protects healthy malaria-naive adults against Plasmodium falciparum sporozoite challenge.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.158

Reducing empiricism in malaria vaccine design

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.158

Towards validated assays for key immunological outcomes in malaria vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.158

Comparative decline in funding of European Commission malaria vaccine projects: what next for the European scientists working in this field?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.158

Efficacy of RTS,S/AS01E malaria vaccine and exploratory analysis on anti-circumsporozoite antibody titres and protection in children aged 5-17 months in Kenya and Tanzania: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.158

Protection against a malaria challenge by sporozoite inoculation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.158

Genetically modified Plasmodium parasites as a protective experimental malaria vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.158

Live attenuated malaria vaccine designed to protect through hepatic CD8⁺ T cell immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.158

Genetically engineered, attenuated whole-cell vaccine approaches for malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.158

Addressing the needs and gaps in safety assessment of vaccines during clinical trials in resource limited countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.158

inferred from DOI database lookup

7 January 2021

based on heuristic

The intolerable burden of malaria: a new look at the numbers.

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.158

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1586/ERV.11.158

0 references